
Tactile Systems (TCMD) Stock Forecast & Price Target
Tactile Systems (TCMD) Analyst Ratings
Bulls say
Tactile Systems Tech is expected to continue its strong performance and potential for growth in the advanced compression and head and neck market. Their current valuation is favorable and they have seen increased revenue guidance and a 9% annual growth rate. Risks include slower sales growth, limitations on sales force leverage, and competition in the Airway Clearance market, but the company is focused on expanding evidence and improving access to care for patients with chronic conditions. Their increasing referrals per territory and efforts to gain 100% market share in a specific medical indication are positive indicators for their future success.
Bears say
Tactile Systems Tech is showing positive growth with its lymphedema product sales, but the April 13th Medicare prior authorization requirement may cause some near-term moderation in order volumes due to additional administrative steps and may hinder sales force productivity. While there could be potential sources of upside including faster adoption within the VA channel and new product releases, there are also risks such as slower-than-expected uptake in commercial channels and competition. Overall, the company's strong position and long-term vision, combined with an attractive valuation, make it a Buy in the analyst's eyes.
This aggregate rating is based on analysts' research of Tactile Systems and is not a guaranteed prediction by Public.com or investment advice.
Tactile Systems (TCMD) Analyst Forecast & Price Prediction
Start investing in Tactile Systems (TCMD)
Order type
Buy in
Order amount
Est. shares
0 shares